Loading
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Jan 2026 for Zivo Bioscience, Inc., €84k.
Filing timeline
BuySaleAlison A. Cornell
Insider track record
Disclosed buys
5
Disclosed sells
0
Signal history
Closed purchases
Market purchases
5
Positive at T+90
60%
Median T+90
+6.6%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -38.0%Entry US$10.49 · Close 19 Oct 2026 US$6.50
- +98.2%Entry US$9.08 · Close at T+365 US$18.00
- +605.7%Entry US$2.82 · Close at T+365 US$19.90
- -93.2%Entry US$17.22 · Close at T+365 US$1.17
- -8.7%Entry US$25.50 · Close at T+365 US$23.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Alison A. Cornell: trading record in brief
Five purchases and no sale: the open-market trades filed by Alison A. Cornell are all purchases, all at Zivo Bioscience, Inc., where the listed title is Director. They add up to EUR 315,019, with a median of EUR 61,303. The three largest are dated August 22, 2024 (EUR 89,948), January 26, 2026 (EUR 84,324) and June 2, 2021 (EUR 61,303).
The record holds 14 filings between March 17, 2016 and January 28, 2026. Zivo Bioscience accounts for 11 of them; the other 3 concern International Flavors & Fragrances Inc, under the title EVP & CFO. Alongside the purchases, 9 grants are on file.
Within 30 days of colleagues at Zivo Bioscience, Inc., Cornell has 4, 2 and 2 own market trades, in that order, every one in the same direction. The colleagues, in the same order: Christopher D. Maggiore, John Bernard Payne and Mark E. Strome. The busiest year is 2024 with 6 filings. One filing, a purchase, falls in the last twelve months. Median publication delay: 2 days.
Companies and markets linked to Alison A. Cornell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
11,709 shares@ US$8.5426.8% of flowCommon StockSEC:0001654954-26-000652:0
Canonical exit: 26 Apr 2026 (T+90)
8,281 shares0Common StockSEC:0001654954-25-000101:1
1,516 shares0Common StockSEC:0001654954-25-000101:0
11,990 shares@ US$8.3428.6% of flowCommon StockSEC:0001654954-24-011075:0
Canonical exit: 20 Nov 2024 (T+90)
6,273 shares0Common StockSEC:0001654954-24-007746:0
95,134 shares@ US$7.9668.9% of flowCommon StockSEC:0001654954-24-007462:1
60,724 sharesCommon StockSEC:0001654954-24-007462:0
37,688 shares0Common StockSEC:0001654954-24-007348:0
41,666 shares@ US$1.2014.4% of flowCommon StockSEC:0001654954-24-000193:0
Canonical exit: 1 Apr 2024 (T+90)
12,000 shares@ US$3.0010.8% of flowCommon StockSEC:0001654954-22-016511:0
Canonical exit: 13 Mar 2023 (T+90)
15,000 shares@ US$4.9919.5% of flowCommon StockSEC:0001078782-21-000535:0
Canonical exit: 31 Aug 2021 (T+90)
2,503 shares@ US$119.8193.4% of flowCommon StockSEC:0001225208-16-032476:0
495 shares0Common StockSEC:0001225208-16-030018:0
184 shares@ US$110.306.6% of flowCommon StockSEC:0001225208-16-030018:1
14 of 14 declarations
